Need Help?
No Article Versions Notes Found
Cite
Harlos, C.; Metser, U.; Poon, R.; MacCrostie, P.; Mason, W. 18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis. Curr. Oncol. 2019, 26, 458-465. https://doi.org/10.3747/co.26.4583
Harlos C, Metser U, Poon R, MacCrostie P, Mason W. 18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis. Current Oncology. 2019; 26(4):458-465. https://doi.org/10.3747/co.26.4583
Chicago/Turabian StyleHarlos, C., U. Metser, R. Poon, P. MacCrostie, and W. Mason. 2019. "18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis" Current Oncology 26, no. 4: 458-465. https://doi.org/10.3747/co.26.4583
APA StyleHarlos, C., Metser, U., Poon, R., MacCrostie, P., & Mason, W. (2019). 18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis. Current Oncology, 26(4), 458-465. https://doi.org/10.3747/co.26.4583
